- Betapace, Betapace AF, Sorine
- Dosage: 40–160 mg q12h
- Formulations: T: 80, 120, 160, 240
- Comments (Metabolism): Prolongs QT interval and requires initiation in hospital; adverse events include torsades de pointes, HF, exacerbation of COPD/bronchospasm (K); renal dosing required if CrCl <60mL/min, contraindicated if CrCl <40ml/min
Notes:
* following a drug name indicates the drug is available as a generic formulation.
BC following a drug name indicates the drug is listed in the 2023 American Geriatrics Society Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults.
K = renal elimination; L = hepatic elimination